Application of dose effect in identification of irregular antibodies--a case report
-
摘要: 目的 应用剂量效应分析抗-Ce联合抗-JKa抗体引起的疑难配血。方法 对患者进行ABO及Rh血型鉴定,Coombs试验进行抗体筛查,在盐水、抗人球蛋白和凝聚胺介质采用两套谱细胞进行不规则抗体鉴定及不规则抗体效价的测定。结果 两套谱细胞反应格局结果相同,患者血清存在抗-Ce和抗-Jka抗体。结论 剂量效应在Rh和Kidd血型系统不规则抗鉴定中有重要应用价值,抗-Ce和抗-Jka抗体引起患者配血困难。Abstract: Objective To analyze the difficult blood matching caused by anti-Ce combined with anti-JKaantibody by dose effect.Methods ABO and Rh blood typing, Coombs test for antibody screening, irregular antibodies were identified by two sets of panel cells in saline, anti human globulin and condensed amine medium, determination of irregular antibody titer.Results The results of the two sets of panel cell were the same, there were anti-Ce and anti-JKaantibodies in the patient's serum.Conclusion Dose effect may have an important application value in irregular antibody identification of Rh and Kidd blood group system. Anti-Ce and anti-JKaantibodies could cause difficulty in blood matching.
-
Key words:
- dose effect /
- anti-Ce /
- anti-JKa /
- muti panel cells application
-
表 1 患者间接抗人球试验结果
序号 Rh-hr D C E c e Cw K k M N S s P1 Lea Leb Jka Jkb Dia Kpa Kpb Jsa Jsb Lua Lub IS poly IAT 1 R1R1W + + 0 0 + + 0 + 0 + + + + + 0 + + 0 0 + n.t. n.t. 0 + 0 2+S 2+ 2 R2R2 + 0 + + 0 0 0 + + 0 0 0 + 0 + + 0 0 0 + n.t. n.t. 0 + 0 0 1+W 3 rrK+* 0 0 0 + + 0 + + + + 0 + 0 0 + 0 + 0 0 + n.t. n.t. + + 0 2+S 1+ 注:*Cob+。 表 2 患者谱细胞1反应格局
序号 Rh-hr D C E c e Cw K k M N S s P1 Lea Leb Jka Jkb Dia Kpa Kpb Jsa Jsb Lua Lub IS poly IAT 1 R1R1K+ + + 0 0 + 0 + 0 + + + 0 0 0 + + + 0 0 + n.t. n.t. 0 + 0 2+S 2+S 2 R2R2 + 0 + + 0 0 0 + + 0 0 + + 0 + + 0 0 0 + n.t. n.t. 0 + 0 0 1+W 3 r’r 0 + 0 + + 0 0 + + + 0 + 0 0 0 + + 0 0 + n.t. n.t. 0 + 0 2+S 2+S 4 r''r 0 0 + + + 0 0 + + 0 + + 0 0 + + + 0 0 + n.t. n.t. 0 + 0 2+ 1+ 5 rrK+ 0 0 0 + + 0 + + + + + + + 0 + 0 + 0 0 + n.t. n.t. + + 0 2+ 2+S 6 R0r + 0 0 + + 0 0 + 0 + 0 + + 0 + + 0 0 0 + n.t. n.t. 0 + 0 2+ 2+ 7 R1R1W + + 0 0 + + 0 + + + + + + 0 + 0 + 0 0 + n.t. n.t. + + 0 2+S 2+S 8 rr 0 0 0 + + 0 0 + + + 0 + + + 0 0 + 0 0 + n.t. n.t. 0 + 0 1+S 1+ 9 R1R2 + + + + + 0 0 + 0 + + + + 0 + + 0 0 0 + n.t. n.t. 0 + 0 1+S 2+S 10 R1R1 + + 0 0 + 0 0 + + 0 0 + + + 0 0 + 0 + + n.t. n.t. 0 + 0 2+S 2+S 11 rr 0 0 0 + + 0 0 + + 0 + 0 + 0 0 + + 0 0 + n.t. n.t. 0 + 0 1+S 2+S 自c 0 0 0 表 3 患者谱细胞2反应格局
序号 Rh-Hr Kell Duffy Kidd Lewis P MNS Luther Xg 试管法 C D E c e CW f V K k Kpa Kpb Jsa Jsb Fya Fyb Jka Jkb Lea Leb P1 M N S s Lua Lub Xga IS IAT poly 1 + + 0 0 + + / / 0 + 0 + / + + 0 + 0 0 + + + 0 0 + 0 + + 0 3+ 3+S 2 + + 0 0 + 0 / / + + 0 + 0 + 0 + 0 + 0 + + + + + 0 0 + / 0 3+ 3+S 3 0 + + + 0 0 / / + + 0 + 0 + + + 0 + + 0 + 0 + + + 0 W / 0 0 0 4 0 + 0 + + 0 / / 0 + 0 + / + + 0 + 0 0 + + + 0 + 0 + + + 0 3+W 3+S 5 + 0 0 0 + 0 / / 0 + 0 + / + + 0 + + 0 + + 0 + + + 0 + + 0 3+ 3+S 6 0 0 + + 0 0 / / 0 + 0 + / + 0 + + + 0 + + + 0 + 0 0 + + 0 1+ 0 7 0 0 0 + + 0 / / 0 + 0 + 0 + + 0 + 0 0 0 0 + + 0 + 0 + / 0 3+ 3+ 8 0 0 0 + + 0 / / 0 + + + 0 + + 0 0 + + + + + + 0 + 0 + / 0 3+W 3+ 9 0 0 0 + + 0 / / + 0 0 + / + 0 + 0 + + 0 + + + 0 + 0 + + 0 2+ 3+S 10 0 0 0 + + 0 / / 0 + 0 + 0 + + + + 0 0 + + 0 + + 0 0 + / 0 3+ 3+S 11 + + + 0 + + / / 0 + 0 + 0 + 0 + + + + 0 + + + 0 + 0 + / 0 2+ 3+ 12 W + + + 0 0 / / + + 0 + / + + 0 + + + 0 + 0 + 0 + 0 + / 0 1+ 0 13 0 0 0 + + 0 / / 0 + 0 + / + 0 + 0 + 0 + + 0 + 0 + + + + 0 3+ 3+ 14 + 0 0 + + + / / 0 + 0 + 0 + 0 + 0 + 0 + + + + 0 + 0 + 0 0 3+ 3+ 15 0 + + + + 0 / / 0 + 0 + / + + + + + 0 + 0 + + + + + 0 + 0 1+S 3+ 16 + 0 0 + + 0 / / 0 + + + / + 0 + + + 0 + + + + 0 + 0 + + 0 3+ 3+ 自c 0 0 0 -
[1] 赵桐茂. Rh基因型匹配输血研究进展[J]. 精准医学杂志, 2019, 34(4): 283-286, 301. https://www.cnki.com.cn/Article/CJFDTOTAL-SPAN201904001.htm
[2] Ying Y, Zhang J, Hong X, et al. The Significance of RHD Genotyping and Characteristic Analysis in Chinese RhD Variant Individuals[J]. Front Immunol, 2021, 12: 755661. doi: 10.3389/fimmu.2021.755661
[3] Liu Y, Lv Y, Xu D, et al. The Necessity of Clinical Rh Phenotypic Serological Detection and Homotypic Infusion in Patients with Repeated Blood Transfusion[J]. Med Sci Monit, 2020, 26: e921058.
[4] 孙长杰, 王晓宁, 卢伟伟, 等. 红细胞Kidd血型抗原研究现状及进展[J]. 中国实验诊断学, 2020, 24(2): 340-343. doi: 10.3969/j.issn.1007-4287.2020.02.047
[5] 杨红梅, 邹昕, 郑皆炜, 等. 抗-cE及抗-Jk~b和抗-Mur混合抗体致疑难配血分析——附1例报告[J]. 中国输血杂志, 2020, 33(1): 70-72. https://www.cnki.com.cn/Article/CJFDTOTAL-BLOO202001026.htm
[6] 郝萧, 夏小叶, 姚美雪. 抗-C、e、Jk~a复合抗体引起新生儿溶血1例[J]. 中国输血杂志, 2020, 33(10): 1112-1114. https://www.cnki.com.cn/Article/CJFDTOTAL-BLOO202010037.htm
[7] 王颖, 许志远, 庄光艳, 等. 剂量效应对抗体鉴定的影响[J]. 北京医学, 2019, 41(5): 411-413. https://www.cnki.com.cn/Article/CJFDTOTAL-BJYX201905023.htm
[8] 何屹, 文韬, 袁红. 剂量效应对输血相容性检测影响研究[J]. 中国免疫学杂志, 2021, 37(19): 2381-2384. doi: 10.3969/j.issn.1000-484X.2021.19.014
[9] 邢志勇, 王维娜. 低效价不规则抗体漏检与无效输血的关系及解决对策[J]. 中国输血杂志, 2019, 32(10): 1053-1055. https://www.cnki.com.cn/Article/CJFDTOTAL-BLOO201910027.htm
[10] 刘丽娟, 杜肖刚, 马登峰, 等. Rh表型分布分析及其临床意义[J]. 临床血液学杂志, 2021, 34(10): 740-741. https://www.cnki.com.cn/Article/CJFDTOTAL-LCXZ202110014.htm